79069-16-2

Basic information

• Product Name: Butanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-4-hydroxy-,phenylmethyl ester, (3S)-
• Synonyms: Butanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-4-hydroxy-,phenylmethyl ester, (3S)-;benzyl(S)-3-((tert-butoxycarbonyl)amino)-4-hydroxybutanoate;EOS-61327
• CAS NO: 79069-16-2
• Molecular Formula: C₁₆H₂₃NO₅
• Molecular Weight: 309.35752
• Mol File: 79069-16-2.mol
• Article Data: 49

Chemical Properties

• Melting Point: 57 °C(Solv: ethyl acetate (141-78-6); cyclohexane (110-82-7))
• Boiling Point: 467.4±45.0 °C(Predicted)
• Appearance: /
• Density: 1.154±0.06 g/cm3(Predicted)
• PKA: 11.53±0.46(Predicted)
• CAS DataBase Reference: Butanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-4-hydroxy-,phenylmethyl ester, (3S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Butanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-4-hydroxy-,phenylmethyl ester, (3S)-(79069-16-2)
• EPA Substance Registry System: Butanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-4-hydroxy-,phenylmethyl ester, (3S)-(79069-16-2)

Safety Data

• Hazardous Substances Data: 79069-16-2(Hazardous Substances Data)

Upstream product

• 7536-58-5 BOC-L-aspartic acid 4-benzyl ester 
• 84890-97-1 (S)-3-tert-Butoxycarbonylamino-4-isobutoxycarbonyloxy-4-oxo-butyric acid benzyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 2177-63-1 (S)-2-amino-4-(benzyloxy)-4-oxobutanoic acid 
• 100-51-6 benzyl alcohol 
• 118943-18-3 4-(phenylmethyl) N-[(1,1-dimethylethoxy)carbonyl]-1(2,5-dioxo-1-pyrrolidinyl) L-aspartate 
• 543-27-1 isobutyl chloroformate 
• 138108-83-5 C₂₀H₂₉NO₆ 
• 118517-08-1 (S)-3-tert-Butoxycarbonylamino-4-isopropoxycarbonyloxy-4-oxo-butyric acid benzyl ester 
• 79069-52-6 N-Boc-L-aspartic aldehyde β-benzyl ester 

Downstream Products

• 79069-52-6 N-Boc-L-aspartic aldehyde β-benzyl ester 
• 161529-22-2 benzyl (S)-2-(N-t-butoxycarbonylamino)-4-iodobutanoate 
• 161745-47-7 benzyl 3(S)-<(tert-butoxycarbonylamino)>-4-p-toluenesulfonyl-1-butyrate 
• 204700-16-3 (S)-3-tert-Butoxycarbonylamino-4-(6-chloro-purin-9-yl)-butyric acid benzyl ester 
• 207615-83-6 (S)-3-tert-Butoxycarbonylamino-4-(4-chloro-pyrrolo[2,3-d]pyrimidin-7-yl)-butyric acid benzyl ester 
• 221106-60-1 (S)-3-(tert-butoxycarbonylamino)-4-(tert-butyldimethylsiloxy)butyric acid benzyl ester 
• 117752-82-6 (S)-β-amino-γ-butyrolactone hydrochloride 
• 149193-64-6 3-tert-butoxycarbonylamino-4-methanesulfonyloxy-butyric acid benzyl ester 
• 517877-32-6 (S)-N-[(tert-butoxy)carbonyl]-γ-(3-benzoylthymin-1-yl)-β-homoalanine benzyl ester 
• 517877-41-7 (S)-N-[(tert-butoxy)carbonyl]-γ-(2-amino-6-chloropurin-9-yl)-β-homoalanin benzyl ester 
• 517877-29-1 (S)-N-[(tert-butoxy)carbonyl]-γ-(3-benzoyluracil-1-yl)-β-homoalanine benzyl ester 
• 210962-33-7 benzyl (3S)-3-tert-butoxycarbonylamino-4-(3-cyanophenoxy)butyrate 
• 840525-40-8 benzyl (S)-3-(tert-butoxycarbonylamino)-4-bromobutanoate 
• 540496-34-2 (S)-(2-oxo)oxazolidine-4-acetic acid benzyl ester 

Relevant articles and documents

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

This invention relates to deuterated compounds which are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

Design and Optimization of an Acyclic Amine Series of TRPV4 Antagonists by Electronic Modulation of Hydrogen Bond Interactions

Investigation of TRPV4 as a potential target for the treatment of pulmonary edema associated with heart failure generated a novel series of acyclic amine inhibitors displaying exceptional potency and PK properties. The series arose through a scaffold hopp

Cathepsin K inhibitors and use thereof

The invention relates to compounds and pharmaceutical compositions thereof for treatment or prevention of cathepsin dependent diseases; the compounds and the compositions comprising the compounds can be used as bone absorption inhibitors for treatment of related diseases, wherein the cathepsin includes, but is not limited to, cathepsin K.